Month: September 2017

Card image cap

ICON Chemotherapy Administration Standards & Guidelines published

September 13, 2017
Belinda Bailey and David Eedes of Icon were invited to present the ICON Chemotherapy Administration Standards & Guidelines to delegates on the recent SASCRO/SASMO 2017 Conference. They would like to share the slide set and abstract from the prestigious national event with you on the Icon website. ...
Card image cap

PERSEPHONE Trial report from ASCO – Shorter duration adjuvant trastuzumab for HER2+ breast cancer non-inferior and with fewer cardiac side effects

September 13, 2017
The results of the PERSEPHONE trial, a phase III randomized, multicentre, non-inferiority clinical trial comparing 6 months of adjuvant trastuzumab to the current standard of 12 months, were presented at ASCO in May this year. Over 4,000 women with HER2-positive, early-stage breast cancer were randomised to ...